Idéal Investisseur
Français English
CAC 40 : Market open
8 092,03 pts
-0.32%


Last updated : 15/09/2026 - 15h38

ADOCIA news: financial news, earnings, stock moves and analysts

Live news related to ADOCIA stock (FR0011184241): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.

The latest financial news on ADOCIA mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €3,71 on Euronext Paris, up 4,62% at the last update. This page lists the articles published on ADOCIA stock to track the share price, company announcements and any item likely to influence market perception.

Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
ADOCIA
FR0011184241
Pharmaceuticals & Biotechnology / Biotechnology
3,71 € +4,62 %
High3,74 €
Low3,52 €
Last update : 15/09/2026 - 14:57:00 – Euronext Paris – 15 min delay.
Market open

Latest ADOCIA stock news

The Lyon-based biopharmaceutical company modified the composition of its board of directors during the session of August 18, 2026, with the departure …

Lyon-based biotech company Adocia, specializing in diabetes and obesity treatments, confirms compliance with all eligibility criteria for the PEA-PME.…

On Monday, during the annual scientific conference of the American Diabetes Association, Adocia presented the complete data from its phase 3 trial con…

Adocia has released its Q1 2026 financial results, showing a cash balance of EUR 12.0 million as of March 31, with a quarterly cash burn of EUR 5.1 mi…

The stock of the Lyon-based biotech company marked a significant rebound this Tuesday, April 28, reaching 4.906 euros after closing at 4.644 euros the…

Biopharmaceutical company Adocia has announced the signing of a current account advance agreement with Vester Finance, for a total amount of 6 million…

Adocia announced the completion of the Phase 3 program for BioChaperone® Lispro with its Chinese partner Tonghua Dongbao, showing positive results in …

The Lyon-based biopharmaceutical company Adocia has announced the dates for its financial publications and general assembly for the fiscal year 2026.

Lyon-based biopharmaceutical company Adocia has announced the publication dates for its financial and operational indicators for the year 2026, accord…

Biopharmaceutical company Adocia announces the filing of a patent for its AdoXLong platform, aimed at extending the action of peptides to one month.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA